Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis
Open accessThe DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is a malignant tumor in the digestive system whose incidence and mortality is high-ranking among tumors worldwide. The initiation and progression of CRC is a complex process involving genetic alterations in cancer cells and multiple factors from the surrounding tumor cell microenvironment. As accumulating evidence has shown, tumor-associated macrophages (TAMs)—as abundant and active infiltrated inflammatory cells in the tumor microenvironment (TME)—play a crucial role in CRC. This review focuses on the different mechanisms of TAM in CRC, including switching of phenotypical subtypes; promoting tumor proliferation, invasion, and migration; facilitating angiogenesis; mediating immunosuppression; regulating metabolism; and interacting with the microbiota. Although controversy remains in clinical evidence regarding the role of TAMs in CRC, clarifying their significance in therapy and the prognosis of CRC may shed new light on the optimization of TAM-centered approaches in clinical care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One potential approach is to modulate the colorectal TME by inhibiting signaling molecules or pathways that promote the recruitment of monocytes and macrophages to the tumor site, such as the CCL2/CCR2 and CSF-1/CSF-1R pathways [41,95].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In CRC, tumor-associated macrophages (TAMs), which are polarized towards an M2-like phenotype, have been demonstrated to enhance tumor proliferation, invasion, and metastasis, stimulate tumor-related angiogenesis, and inhibit the antitumor immune response [95].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 2×
“Studies have shown that TAMs predominantly come from circulating inflammatory monocytes, which can be recruited by multiple chemokines including CC-chemokine ligands 2 and 5 (CCL2 and CCL5) and cytokines colony stimulating factor 1(CSF1) [28,29].”
BackgroundMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“M1 macrophages have the capability to promote the Th1 response and engulf and kill target tumor cells [36].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“TNF-γ can induce monocyte or macrophage recruitment to the TME of colon cancer and inhibit their differentiation into TAMs in vivo [137].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · cited 1×
“TAMs primarily have the phenotype of M2-like macrophages in the TME and promote tumor immunosuppression by promoting tumor angiogenesis or by indirectly inducing interactions between immune cells in the TME [39].”
BackgroundMacrophage plasticity, polarization, and function in health and disease
Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 1×
“This process results in macrophage recruitment and phenotypic polarization towards the M2 macrophage state, mediated by hypoxia inducible factor-1α (HIF1α) [102].”
BackgroundRecommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · cited 1×
“Fusobacterium nucleatum is selectively recruited by tumor-associated neutrophils, myeloid-derived suppressor cells, and M2 macrophages during the development of colon cancer, promoting tumor growth [128].”
BackgroundMacrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107 · cited 1×
“Additionally, downregulation of the peroxisome proliferator-activated receptor-γ (PPAR-γ) pathway in TAMs leads to increased secretion of itaconate, which functions as a regulator of M2 macrophages and promotes tumor progression [110,111].”
BackgroundDavies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096 · cited 1×
“The progenitor cells receive inflammatory mediator stimulation signals and differentiate respectively into mature macrophages with different phenotypes [26,27].”
BackgroundFrom Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980
Immunotherapy in colorectal cancer: Rationale, challenges and potential
Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954
Tumor-Associated Macrophages in Tumor Immunity
Pan, Y., Yu, Y., Wang, X., & Zhang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583084 · Cited by 1,872
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
Metabolic Reprograming in Macrophage Polarization
Galván-Peña, S., & O’Neill, L. A. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00420 · Cited by 944
Tumor-associated macrophages: from basic research to clinical application
Yang, L., & Zhang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0430-2 · Cited by 847 · cited 1×
“TAMs recruit regulatory T cells (Tregs) by secreting the chemokine CCL2, suppress the antitumor immune response of T cells, and interrupt immune cell interactions, resulting in the immunosuppressive microenvironment of CRC [25,44,45].”
BackgroundProgress in tumor-associated macrophage (TAM)-targeted therapeutics
Ngambenjawong, C., Gustafson, H. H., & Pun, S. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.010 · Cited by 840
Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q., Dou, R., & Xiong, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0976-4 · Cited by 833 · cited 2×
“found that TAMs secrete IL-6 to induce EMT, which enhances CRC migration and invasion by regulating the JAK2/STAT3/miR-506-3p/FoxQ1 axis [69].”
BackgroundAblation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
Patsouris, D., Li, P.-P., Thapar, D., Chapman, J., Olefsky, J. M., & Neels, J. G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.015 · Cited by 804 · cited 1×
“Alternately, activated M2 macrophages participate in the uptake of fatty acids and the reprogramming of lipid metabolism by extracting, breaking down, and/or storing free fatty acids released by fat cells as triglycerides [108].”
BackgroundTumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Kim, J., & Bae, J.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/6058147 · Cited by 802
Zhu, Y., Herndon, J. M., Sojka, D. K., Kim, K.-W., Knolhoff, B. L., Zuo, C., Cullinan, D. R., Luo, J., Bearden, A. R., Lavine, K. J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.014 · Cited by 801
Colorectal Cancer and Nutrition
Thanikachalam, K., & Khan, G. (2019) · Nutrients · doi:10.3390/nu11010164 · Cited by 729
Regulation of macrophage development and function in peripheral tissues
Lavin, Y., Mortha, A., Rahman, A., & Merad, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3920 · Cited by 680 · cited 10×
“M2 macrophages are typically divided into four subtypes according to their different stimuli: M2a (typically induced by IL-4 and IL-23); M2b (induced by immune complexes with IL-1β or LPS); M2c (induced by IL-10, transforming growth factor beta, and glucocorticoids); and M2d (induced by IL-6) [12,38].”
BackgroundInfluentialChemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., De Palma, A., Mauri, P., Monegal, A., Rescigno, M., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101956 · Cited by 650
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
Lan, J., Sun, L., Xu, F., Liu, L., Hu, F., Song, D., Hou, Z., Wu, W., Luo, X., Wang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0014 · Cited by 643
Itaconate: the poster child of metabolic reprogramming in macrophage function
O’Neill, L. A. J., & Artyomov, M. N. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0128-5 · Cited by 629
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Bowman, R. L., Klemm, F., Akkari, L., Pyonteck, S. M., Sevenich, L., Quail, D. F., Dhara, S., Simpson, K., Gardner, E. E., Iacobuzio-Donahue, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.052 · Cited by 619
Metabolic Regulation of Macrophage Polarization in Cancer
Mehla, K., & Singh, P. K. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.10.007 · Cited by 617
Macrophages in intestinal homeostasis and inflammation
Bain, C. C., & Mowat, A. M. (2014) · Immunological Reviews · doi:10.1111/imr.12192 · Cited by 611
Georgoudaki, A.-M., Prokopec, K. E., Boura, V. F., Hellqvist, E., Sohn, S., Östling, J., Dahan, R., Harris, R. A., Rantalainen, M., Klevebring, D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.084 · Cited by 609 · cited 1×
“investigated the effect of immune checkpoint therapy by inhibiting the expression of macrophage receptor with collagenous structure (MARCO) by TAMs, which repolarized TAMs to the M1 type in a mouse MC38 colon cancer model and induced antitumor activity [140].”
BackgroundHigh Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Forssell, J., Öberg, A., Henriksson, M. L., Stenling, R., Jung, A., & Palmqvist, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2073 · Cited by 566
Cancer registration in China and its role in cancer prevention and control
Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., Wang, S., Sun, K., Matsuda, T., Bray, F., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30073-5 · Cited by 497
Halama, N., Zoernig, I., Berthel, A., Kahlert, C., Klupp, F., Suarez-Carmona, M., Suetterlin, T., Brand, K., Krauss, J., Lasitschka, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.005 · Cited by 495
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
Cooks, T., Pateras, I. S., Jenkins, L. M., Patel, K. M., Robles, A. I., Morris, J., Forshew, T., Appella, E., Gorgoulis, V. G., & Harris, C. C. (2018) · Nature Communications · doi:10.1038/s41467-018-03224-w · Cited by 482
Yang, Q., Guo, N., Zhou, Y., Chen, J., Wei, Q., & Han, M. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.004 · Cited by 471
Edin, S., Wikberg, M. L., Dahlin, A. M., Rutegård, J., Öberg, Å., Oldenborg, P.-A., & Palmqvist, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047045 · Cited by 454
Colorectal Cancer Immunotherapy: Options and Strategies
Johdi, N. A., & Sukor, N. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01624 · Cited by 452
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
Fu, L.-Q., Du, W.-L., Cai, M.-H., Yao, J.-Y., Zhao, Y.-Y., & Mou, X.-Z. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104119 · Cited by 415
Chun, E., Lavoie, S., Michaud, M., Gallini, C. A., Kim, J., Soucy, G., Odze, R., Glickman, J. N., & Garrett, W. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.024 · Cited by 402 · cited 4×
“Furthermore, mutant p53 regulates macrophages through exosomes miR-1246 to increase the activity of TGF-β and promote the anti-inflammatory immunosuppression of macrophages [98].”
BackgroundInfluentialYu, L. C.-H. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0483-8 · Cited by 399
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Li, X., Shao, C., Shi, Y., & Han, W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0578-4 · Cited by 381
Immune cells as mediators of solid tumor metastasis
DeNardo, D. G., Johansson, M., & Coussens, L. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9100-0 · Cited by 372
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Lu, T., Ramakrishnan, R., Altiok, S., Youn, J.-I., Cheng, P., Celis, E., Pisarev, V., Sherman, S., Sporn, M. B., & Gabrilovich, D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45862 · Cited by 367
Tumor promoting role of anti-tumor macrophages in tumor microenvironment
Goswami, K. K., Ghosh, T., Ghosh, S., Sarkar, M., Bose, A., & Baral, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.04.005 · Cited by 329
Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Netea-Maier, R. T., Smit, J. W. A., & Netea, M. G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.10.037 · Cited by 326
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Erreni, M., Mantovani, A., & Allavena, P. (2011) · Cancer Microenvironment · doi:10.1007/s12307-010-0052-5 · Cited by 325
Macrophages of distinct origins contribute to tumor development in the lung
Loyher, P.-L., Hamon, P., Laviron, M., Meghraoui-Kheddar, A., Goncalves, E., Deng, Z., Torstensson, S., Bercovici, N., Baudesson de Chanville, C., Combadière, B., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180534 · Cited by 298
Macrophages as Key Drivers of Cancer Progression and Metastasis
Nielsen, S. R., & Schmid, M. C. (2017) · Mediators of Inflammation · doi:10.1155/2017/9624760 · Cited by 298
Yin, Y., Yao, S., Hu, Y., Feng, Y., Li, M., Bian, Z., Zhang, J., Qin, Y., Qi, X., Zhou, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1283 · Cited by 296 · cited 1×
“Infiltration of CD68+ TAMs and M2 TAMs is associated with poor CRC prognosis [69,70,166].”
BackgroundSelf-citationThe origin and function of tumor-associated macrophages
Liu, Y., & Cao, X. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.83 · Cited by 291
Herrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12096 · Cited by 289
Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
Rodriguez, P. C., Ochoa, A. C., & Al-Khami, A. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00093 · Cited by 285
Smith, L. K., Boukhaled, G. M., Condotta, S. A., Mazouz, S., Guthmiller, J. J., Vijay, R., Butler, N. S., Bruneau, J., Shoukry, N. H., Krawczyk, C. M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.006 · Cited by 281
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
Weiss, J. M., Davies, L. C., Karwan, M., Ileva, L., Ozaki, M. K., Cheng, R. Y. S., Ridnour, L. A., Annunziata, C. M., Wink, D. A., & McVicar, D. W. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99169 · Cited by 267 · cited 1×
“Classically activated M1 macrophages induce glycolysis via the AKT/mTOR/HIF pathway and use the low-efficiency aerobic glycolysis pathway to enact the host defense against pathogens, including producing MAPK-mediated ROS to eliminate bacteria or tumor cells [104].”
BackgroundThe role of tumor-associated macrophage in breast cancer biology.
(2018) · PubMed · doi:10.14670/hh-11-916 · Cited by 257
Egawa, M., Mukai, K., Yoshikawa, S., Iki, M., Mukaida, N., Kawano, Y., Minegishi, Y., & Karasuyama, H. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.014 · Cited by 257
Wu, J., Li, Q., & Fu, X. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.03.003 · Cited by 253
Local Arginase 1 Activity Is Required for Cutaneous Wound Healing
Campbell, L., Saville, C. R., Murray, P. J., Cruickshank, S. M., & Hardman, M. J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.164 · Cited by 246
Liu, J., Zhang, N., Li, Q., Zhang, W., Ke, F., Leng, Q., Wang, H., Chen, J., & Wang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019495 · Cited by 245
Self-citationTumor-associated macrophages: role in cancer development and therapeutic implications
Salmaninejad, A., Valilou, S. F., Soltani, A., Ahmadi, S., Abarghan, Y. J., Rosengren, R. J., & Sahebkar, A. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00453-z · Cited by 245
Wang, X., & Huycke, M. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.040 · Cited by 242
Barberá‐Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C., & Sampsel, J. W. (2002) · PubMed · Cited by 233
Waniczek, D., Lorenc, Z., Śnietura, M., Wesecki, M., Kopec, A., & Muc-Wierzgoń, M. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0463-9 · Cited by 228
Ge, Z., & Ding, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.590941 · Cited by 222
Zhou, Q., Peng, R.-Q., Wu, X.-J., Xia, Q., Hou, J.-H., Ding, Y., Zhou, Q.-M., Zhang, X., Pang, Z.-Z., Wan, D.-S., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-13 · Cited by 219
Cancer: an old disease, a new disease or something in between?
David, A. R., & Zimmerman, M. R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2914 · Cited by 214
Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer
Funada, Y., Noguchi, T., Kikuchi, R., Takeno, S., Uchida, Y., & Gabbert, H. (2003) · Oncology Reports · doi:10.3892/or.10.2.309 · Cited by 205
The gastrointestinal microbiota and colorectal cancer
Keku, T. O., Dulal, S., Deveaux, A., Jovov, B., & Han, X. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2012 · Cited by 205
Yu, X., Wang, D., Wang, X., Sun, S., Zhang, Y., Wang, S., Miao, R., Xu, X., & Qu, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1014-x · Cited by 204
Kondo, A., Yamashita, T., Tamura, H., Zhao, W., Tsuji, T., Shimizu, M., Shinya, E., Takahashi, H., Tamada, K., Chen, L., et al. (2010) · Blood · doi:10.1182/blood-2009-12-255125 · Cited by 201
Kawano, Y., Nakae, J., Watanabe, N., Kikuchi, T., Tateya, S., Tamori, Y., Kaneko, M., Abe, T., Onodera, M., & Itoh, H. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.009 · Cited by 197
Mikuła-Pietrasik, J., Uruski, P., Tykarski, A., & Książek, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2663-1 · Cited by 197
Chen, T., Li, Q., Wu, J., Wu, Y., Peng, W., Li, H., Wang, J., Tang, X., Peng, Y., & Fu, X. (2018) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-018-2233-x · Cited by 195
Van Overmeire, E., Laoui, D., Keirsse, J., Van Ginderachter, J. A., & Sarukhan, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00127 · Cited by 180
Wunderlich, C. M., Ackermann, P. J., Ostermann, A. L., Adams-Quack, P., Vogt, M. C., Tran, M.-L., Nikolajev, A., Waisman, A., Garbers, C., Theurich, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03773-0 · Cited by 177
Zhu, C., Kros, J. M., Cheng, C., & Mustafa, D. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox081 · Cited by 176
Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N., & Muschel, R. J. (2016) · Oncogene · doi:10.1038/onc.2016.107 · Cited by 173
Sanchez-Lopez, E., Flashner-Abramson, E., Shalapour, S., Zhong, Z., Taniguchi, K., Levitzki, A., & Karin, M. (2016) · Oncogene · doi:10.1038/onc.2015.326 · Cited by 162
Yang, Y., Li, L., Xu, C., Wang, Y., Wang, Z., Chen, M., Jiang, Z., Pan, J., Yang, C., Li, X., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-320777 · Cited by 161
Intratumoral macrophage counts correlate with tumor progression in colorectal cancer
Kang, J., Chen, J., Lee, C., Chang, J., & Shieh, Y. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21617 · Cited by 161
Han, Q., Shi, H., & Liu, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.023 · Cited by 159
Feng, Q., Chang, W., Mao, Y., He, G., Zheng, P., Tang, W., Wei, Y., Ren, L., Zhu, D., Ji, M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2076 · Cited by 152
Khorana, A. A., Ryan, C. K., Cox, C., Eberly, S., & Sahasrabudhe, D. M. (2003) · Cancer · doi:10.1002/cncr.11152 · Cited by 152
De Santa, F., Vitiello, L., Torcinaro, A., & Ferraro, E. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7420 · Cited by 151
Koelzer, V. H., Canonica, K., Dawson, H., Sokol, L., Karamitopoulou-Diamantis, E., Lugli, A., & Zlobec, I. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1106677 · Cited by 148
Yang, C., Wei, C., Wang, S., Shi, D., Zhang, C., Lin, X., Dou, R., & Xiong, B. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29836 · Cited by 146
Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway
Lian, G., Chen, S., Ouyang, M., Li, F., Chen, L., & Yang, J. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819849068 · Cited by 144
Wang, X., Yang, Y., Moore, D. R., Nimmo, S. L., Lightfoot, S. A., & Huycke, M. M. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.020 · Cited by 141
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
Beyranvand Nejad, E., van der Sluis, T. C., van Duikeren, S., Yagita, H., Janssen, G. M., van Veelen, P. A., Melief, C. J. M., van der Burg, S. H., & Arens, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0881 · Cited by 136
Hao, S., Meng, J., Zhang, Y., Liu, J., Nie, X., Wu, F., Yang, Y., Wang, C., Gu, N., & Xu, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.013 · Cited by 135
Targeting tumor-associated macrophages for cancer immunotherapy
Shu, Y., & Cheng, P. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188434 · Cited by 133
M2‐like macrophages induce colon cancer cell invasion via matrix metalloproteinases
Vinnakota, K., Zhang, Y., Selvanesan, B. C., Topi, G., Salim, T., Sand‐Dejmek, J., Jönsson, G., & Sjölander, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25808 · Cited by 130
Wang, X., Yang, Y., & Huycke, M. M. (2015) · Gut · doi:10.1136/gutjnl-2014-307213 · Cited by 122
The origin and function of tumor-associated macrophages
Yang, Y. Y. Y., Liu, Xuetao, & Cao (2015) · 中国免疫学杂志:英文版 · Cited by 118
Hotchkiss, K. A., Ashton, A. W., Klein, R. S., Lenzi, M. L., Zhu, G. H., & Schwartz, E. L. (2003) · PubMed · Cited by 115
IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor
Chen, L., Wang, S., Wang, Y., Zhang, W., Ma, K., Hu, C., Zhu, H., Liang, S., Liu, M., & Xu, N. (2018) · Oncotarget · doi:10.18632/oncotarget.24734 · Cited by 115
Activated macrophages induce metastatic behavior of colon cancer cells
Jedinak, A., Dudhgaonkar, S. P., & Slíva, D. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.03.004 · Cited by 114
Herbeuval, J.-P., Lelievre, E., Lambert, C., Dy, M., & Genin, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4630 · Cited by 113
Ma, Y., Wu, T., Ling, C., Yu, F., Zhang, J., Cao, P., Gu, L., Wang, H., Xu, H. W., Li, L., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.02.005 · Cited by 112
Self-citationMacrophage-tumor cell interactions regulate the function of nitric oxide
Rahat, M. A., & Hemmerlein, B. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00144 · Cited by 109
T-cell-based immunotherapy in colorectal cancer
Feng, M., Zhao, Z., Yang, M., Ji, J., & Zhu, D. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.10.040 · Cited by 107
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer
Tacconi, C., Ungaro, F., Correale, C., Arena, V., Massimino, L., Detmar, M. J., Spinelli, A., Carvello, M., Mazzone, M., Oliveira, A. I., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3657 · Cited by 103
Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4
Schuette, V., Embgenbroich, M., Ulas, T., Welz, M., Schulte-Schrepping, J., Draffehn, A. M., Quast, T., Koch, K., Nehring, M., König, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605885113 · Cited by 102
Li, J., Li, L., Li, Y., Long, Y., Zhao, Q. S., Ouyang, Y., Bao, W., & Gong, K. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03593-z · Cited by 101
Raisch, J., Rolhion, N., Dubois, A., Darfeuille-Michaud, A., & Bringer, M.-A. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2014.161 · Cited by 100 · cited 1×
“These bacteria colonize colon tumors and stimulate macrophages to produce protumoral factors such as cycoxidase-2 (COX-2) to support key processes in tumor progression [130,131].”
BackgroundMacrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM
Miao, H., Ou, J., Peng, Y., Zhang, X., Chen, Y., Hao, L., Xie, G., Wang, Z., Pang, X., Ruan, Z., et al. (2016) · Nature Communications · doi:10.1038/ncomms11716 · Cited by 100
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
Shen, L., Sundstedt, A., Ciesielski, M., Miles, K. M., Celander, M., Adelaiye, R., Orillion, A., Ciamporcero, E., Ramakrishnan, S., Ellis, L., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0036 · Cited by 92
Correlations of Tumor-associated Macrophage Subtypes with Liver Metastases of Colorectal Cancer
Cui, Y.-L., Li, H.-K., Zhou, H.-Y., Zhang, T., & Li, Q. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.1003 · Cited by 90
Maisonneuve, C., Tsang, D. K. L., Foerster, E. G., Robert, L. M., Mukherjee, T., Prescott, D., Tattoli, I., Lemire, P., Winer, D. A., Winer, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108677 · Cited by 90
Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment
Malekghasemi, S., Majidi, J., Baghbanzadeh, A., Abdolalizadeh, J., Baradaran, B., & Maleki, L. A. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.066 · Cited by 89
Xu, H., Zhang, Y., Peña, M. M. O., Pirisi, L. A., & Creek, K. E. (2017) · Carcinogenesis · doi:10.1093/carcin/bgw121 · Cited by 87
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
Pagano, E., Elias, J. E., Schneditz, G., Saveljeva, S., Holland, L. M., Borrelli, F., Karlsen, T. H., Kaser, A., & Kaneider, N. C. (2021) · Gut · doi:10.1136/gutjnl-2020-323363 · Cited by 81
Olsson, A., Nakhlé, J., Sundstedt, A., Plas, P., Bauchet, A.-L., Pierron, V., Bruetschy, L., Deronic, A., Törngren, M., Liberg, D., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0098-5 · Cited by 78
Zhuyan, J., Chen, M., Zhu, T., Bao, X., Zhen, T., Xing, K., Wang, Q., & Zhu, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00453-9 · Cited by 78
Korehisa, S., Oki, E., Iimori, M., Nakaji, Y., Shimokawa, M., Saeki, H., Okano, S., Oda, Y., & Maehara, Y. (2018) · International Journal of Cancer · doi:10.1002/ijc.31107 · Cited by 75
Wang, H., Shao, Q., Sun, J., Ma, C., Gao, W., Wang, Q., Zhao, L., & Qu, X. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1122157 · Cited by 71
Self-citationCavnar, M. J., Turcotte, S., Katz, S. C., Kuk, D., Gönen, M., Shia, J., Allen, P. J., Balachandran, V. P., D’Angelica, M. I., Kingham, T. P., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5812-8 · Cited by 71
Yuan, Q., Gu, J., Zhang, J., Liu, S., Wang, Q., Tian, T., Chen, Z., & Zhang, J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108724 · Cited by 70
Self-citationMatos, A. I., Carreira, B., Peres, C., Moura, L. I. F., Conniot, J., Fourniols, T., Scomparin, A., Martínez-Barriocanal, Á., Arango, D., Conde, J. P., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.017 · Cited by 68
Gut mycobiome: A promising target for colorectal cancer
Qin, X., Gu, Y., Liu, T., Wang, C., Zhong, W., Wang, B., & Cao, H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188489 · Cited by 66
Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma
Badawi, M., Abouelfadl, D. M., El-Sharkawy, S. L., AbdEl-Aal, W. E., & Abbas, N. F. (2015) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2015.044 · Cited by 66
Kim, Y.-H., Wen, X., Bae, J. M., Kim, J. H., Cho, N., & Kang, G. H. (2018) · Histopathology · doi:10.1111/his.13674 · Cited by 65
Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis
Coburn, L. A., Singh, K., Asim, M., Barry, D. P., Allaman, M. M., Al-Greene, N. T., Hardbower, D. M., Polosukhina, D., Williams, C. S., Delgado, A. G., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0492-9 · Cited by 62
Macrophages in Colorectal Cancer Liver Metastases
Cortese, N., Soldani, C., Franceschini, B., Barbagallo, M., Marchesi, F., Torzilli, G., & Donadon, M. (2019) · Cancers · doi:10.3390/cancers11050633 · Cited by 61
Wang, X., Luo, X., Chen, C., Tang, Y., Li, L., Mo, B., Liang, H., & Yu, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0124-z · Cited by 54
Mola, S., Pandolfo, C., Sica, A., & Porta, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186866 · Cited by 47
Zhao, G., Liu, L., Peek, R. M., Hao, X., Polk, D. B., Li, H., & Yan, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.750182 · Cited by 47
Lupuţ, L., Licărete, E., Sesărman, A., Pătraș, L., Alupei, M. C., & Banciu, M. (2017) · Oncology Reports · doi:10.3892/or.2017.5466 · Cited by 45
Mogi, K., Yoshihara, M., Iyoshi, S., Kitami, K., Uno, K., Tano, S., Koya, Y., Sugiyama, M., Yamakita, Y., Nawa, A., et al. (2021) · Cancers · doi:10.3390/cancers13061352 · Cited by 45
PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells
Gao, L., Zhou, Y. N., Zhou, S., Yu, X.-J., Xu, J., Zuo, L., Luo, Y., & Li, X. (2016) · Oncology Reports · doi:10.3892/or.2016.5216 · Cited by 44
Mai, S., Liu, L., Jiang, J., Ren, P., Diao, D., Wang, H., & Cai, K. (2020) · Cell Proliferation · doi:10.1111/cpr.12960 · Cited by 44
Self-citationZhu, Y. J., Zhou, J., Feng, Y., Chen, L., Zhang, L., Yang, F., Zha, H., Wang, X., Han, X., Shu, C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00087 · Cited by 43
Huang, H., Chang, C., Wang, C., & Lin, K. (2021) · Cells · doi:10.3390/cells10010067 · Cited by 43
Immune cell interplay in colorectal cancer prognosis
Norton, S. E., Ward-Hartstonge, K. A., Taylor, E. S., & Kemp, R. A. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i10.221 · Cited by 40
PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6‐P38 MAPK pathway
Cheng, Y., Zhu, Y., Xu, W., Xu, J., Yang, M., Chen, P., Zhao, J., Geng, L., & Gong, S. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22822 · Cited by 40
Wan, G., Xie, M., Yu, H., & Chen, H. (2018) · Innate Immunity · doi:10.1177/1753425918801496 · Cited by 40
Sui, H. X., Tan, H., Fu, J., Song, Q., Jia, R., Han, L., Lv, Y., Zhang, H., Zheng, D., Dong, L., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201903011r · Cited by 39
MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth
Phinney, B. B., Ray, A. L., Peretti, A. S., Jerman, S., Grim, C., Pinchuk, I. V., & Beswick, E. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01857 · Cited by 37
Rubio‐Terres, C., & Schmidt, P. T. (2018) · Anticancer Research · doi:10.21873/anticanres.12664 · Cited by 36
Cardoso, A., Pinto, M., Pinto, A., Pinto, M., Monteiro, C., Oliveira, M., Santos, S., Relvas, J., Seruca, R., Mantovani, A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1466-8 · Cited by 36
Zhang, L.-L., Lian-feng, Z., & Shi, Y. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0002 · Cited by 35
Suárez-López, L., Kong, Y. W., Sriram, G., Patterson, J. C., Rosenberg, S., Morandell, S., Haigis, K. M., & Yaffe, M. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607891 · Cited by 34
Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging
Nagai, N., Kudo, Y., Aki, D., Nakagawa, H., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052238 · Cited by 32
Salting the Soil: Targeting the Microenvironment of Brain Metastases
Srinivasan, E. S., Tan, A. C., Anders, C. K., Pendergast, A. M., Sipkins, D. A., Ashley, D. M., Fecci, P. E., & Khasraw, M. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0579 · Cited by 30
Dost, F. S., Kırmızı, B. A., Ensarı, A., İçlı, F., & Akbulut, H. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.12.004 · Cited by 26
Vito, A. D., Orecchia, P., Balza, E., Reverberi, D., Scaldaferri, D., Taramelli, R., Noonan, D. M., Acquati, F., & Mortara, L. (2020) · Cancers · doi:10.3390/cancers12030717 · Cited by 23
Zhang, Y., Wang, J., Wang, W., Tian, J., Yin, K., Tang, X., Ma, J., Xu, H., & Wang, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5414-2 · Cited by 23
Huang, Y., Huang, T., Yadav, V. K., Sumitra, M. R., Tzeng, D. T. W., Wei, P., Shih, J.-W., & Wu, A. T. H. (2020) · PubMed Central · Cited by 22
Fat breakdown: A function for CGI-58 (ABHD5) provides a new piece of the puzzle
Yen, C. E., & Farese, R. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.001 · Cited by 20
Zhu, Z., Zhu, X., Yang, S., Guo, Z., Li, K., Ren, C., Zhou, Y., & Dou, J. (2020) · PubMed · Cited by 19
Yang, J.-M., Lee, H. S., Seo, J. H., Park, J., Gelman, I. H., Lo, E. H., & Kim, K. (2017) · Scientific Reports · doi:10.1038/srep42723 · Cited by 17
Zhao, P., Wang, B., Zhang, Z., Zhang, W., & Liu, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2006-2 · Cited by 16
Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma
Sellner, F., Thalhammer, S., & Klimpfinger, M. (2021) · Cancers · doi:10.3390/cancers13061342 · Cited by 16
Huang, C., & Yu, L. C. (2020) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_75_19 · Cited by 13
Li, L.-N., Liu, Y., Zhang, H., Wu, T., Dai, Y., & Wang, W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241840 · Cited by 11
Macrophages Instruct Aberrant Glycosylation in Colon Cancer by Chemokine and Cytokine Signals
Bronte, V. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-1005 · Cited by 8
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“One potential approach is to modulate the colorectal TME by inhibiting signaling molecules or pathways that promote the recruitment of monocytes and macrophages to the tumor site, such as the CCL2/CCR2 and CSF-1/CSF-1R pathways [41,95].”
Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance
Manzoor, S., Muhammad, J. S., Maghazachi, A. A., & Hamid, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924290 · Cited by 45
“The TME favors the M2 subset of macrophages through various mechanisms (144).”
BackgroundTumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs
Brady, R. V., & Thamm, D. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1176807 · Cited by 35
Cell Therapy as Target Therapy against Colon Cancer Stem Cells
Garza Treviño, E. N., Quiroz Reyes, A. G., Rojas Murillo, J. A., de la Garza Kalife, D. A., Delgado Gonzalez, P., Islas, J. F., Estrada Rodriguez, A. E., & Gonzalez Villarreal, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098163 · Cited by 24
Metadata
- Authors
- Wang, H., Tian, T., & Zhang, J.
- Affiliations
- Guangxi Medical University (CN)
- Beijing Jiaotong University (CN)
- Corresponding author
- Tian, Tian
- Zhang, Jinhua
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-08-06
- Volume
- 22
- Issue
- 16
- Pages
- 8470
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8395168
- OpenAlex
- W3187790888
- Cited by
- 364
- References
- 172
- Citations by year
- 2026: 55 · 2025: 103 · 2024: 89 · 2023: 81 · 2022: 30 · 2021: 6
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Scientific and Technological Innovation Major Base of Guangxi (2018-15-Z04)
- the State Project for Essential Drug Research and Development (2019ZX09301132)
- Guangxi Key Research and Development Program (AB20117001)
- National Natural Science Foundation of China (81972689, 81772497)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor-associated macrophages, colorectal cancer, tumor microenvironment, macrophage polarization, tumor angiogenesis, immunosuppression, cancer metabolism, gut microbiota, tumor cell migration and invasion, prognosis, TAM-targeted therapy
- MeSH terms
- Tumor-Associated Macrophages, Animals, Cell Movement, Humans, Immunotherapy, Neoplasm Invasiveness, Prognosis, Colorectal Neoplasms, Disease Management, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.